Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",1.230960861430561e-08,4.176059234882764,76.05808948535898,"['GPR87', 'CHRM5', 'HTR2B', 'FPR3', 'GPR83', 'ADRA1D', 'MCHR1', 'MC4R', 'GPR171', 'RHO', 'DRD3', 'P2RY12', 'P2RY14', 'F2R', 'HTR1D', 'GPR3', 'SSTR1', 'GPR6', 'SSTR3', 'HCRTR2', 'HCRTR1', 'OPN1SW', 'LPAR6', 'ACKR4', 'NMUR2', 'RGL4', 'GPR18']",5.502395050594608e-06,0,0,27
2,Vitamin D Receptor Pathway WP2877,0.00026634962881225013,2.8147722772277226,23.16754820377922,"['COLEC11', 'STEAP4', 'ABCB1', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'COL13A1', 'NFATC2', 'G0S2', 'PRDM1', 'BMP6', 'THBD', 'SULT1C2', 'CEACAM1', 'TRPV6', 'BGLAP', 'DND1', 'LGALS9']",0.053536532353339224,0,0,18
3,Proximal tubule transport WP4917,0.0003593055862640216,4.327111984282908,34.319784752899515,"['ATP6V0B', 'SLC22A6', 'ABCB1', 'SLC3A1', 'ATP6V0A4', 'SLC5A2', 'SLC22A8', 'ATP6V0C', 'ATP6V1B1', 'ATP6V1F']",0.053536532353339224,0,0,10
4,Gastric acid production WP2596,0.000853663593121882,46.51609756097561,328.68150621623823,"['GRP', 'CCK', 'MUC6']",0.09539690653137031,0,0,3
5,Sleep regulation WP3591,0.001772754948292019,4.73095430737129,29.971638591867286,"['IL18', 'CRH', 'UTS2', 'GHRL', 'DRD3', 'HCRTR2', 'HCRTR1']",0.15848429237730652,0,0,7
6,Cori Cycle WP1946,0.006219753617171623,6.89453125,35.02439100574587,"['TPI1', 'PGAM1', 'ALDOA', 'GAPDH']",0.4270696113725239,0,0,4
7,Glycolysis and Gluconeogenesis WP534,0.007200330664486759,3.508293576822217,17.308616574924088,"['LDHC', 'HK3', 'TPI1', 'PGAM1', 'ENO2', 'ALDOA', 'GAPDH']",0.4270696113725239,0,0,7
8,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.00787847745536749,2.8560413370451223,13.833580683423452,"['FZD1', 'JUN', 'CDKN1B', 'FN1', 'NEFL', 'PFN4', 'NEFM', 'ELK1', 'NEFH']",0.4270696113725239,0,0,9
9,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.009937833285922907,9.300878048780488,42.89012727027354,"['HSD11B1', 'HSD11B2', 'HSD3B1']",0.4270696113725239,0,0,3
10,Metapathway biotransformation Phase I and II WP702,0.01407783066700675,2.056417699378512,8.766825365593325,"['CHST9', 'GPX4', 'GPX3', 'GSTP1', 'GLYAT', 'CYP2C18', 'CYP39A1', 'SULT1C2', 'CYP2A6', 'CHST13', 'GAL3ST2', 'NAT8L', 'CHST4', 'SULT1C4']",0.4270696113725239,0,0,14
11,Peptide GPCRs WP24,0.014144135247350018,3.0200783545543586,12.860868406463519,"['MC4R', 'GNRHR', 'FPR3', 'SSTR1', 'SSTR3', 'HCRTR2', 'HCRTR1']",0.4270696113725239,0,0,7
12,Bile acids synthesis and enterohepatic circulation  WP4389,0.01424026606535218,7.750243902439024,32.951570083797705,"['FGFR4', 'ABCB11', 'MAPK3']",0.4270696113725239,0,0,3
13,Tryptophan metabolism WP465,0.015419014992315492,3.3266703941850713,13.879380498057069,"['TPH1', 'HAAO', 'ALDH1A1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.4270696113725239,0,0,6
14,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.016236659587568633,2.4979321463619795,10.292688582447974,"['TUBB8', 'HSPA8', 'TUBB6', 'CASP8', 'TUBB2A', 'HSPA5', 'TUBA4A', 'HSPA1B', 'HSPA1A']",0.4270696113725239,0,0,9
15,Matrix Metalloproteinases WP129,0.017054966167677283,4.771935096153846,19.428045433155756,"['MMP15', 'MMP19', 'MMP21', 'TIMP4']",0.4270696113725239,0,0,4
16,Myometrial relaxation and contraction pathways WP289,0.018194687716568868,1.930237491127736,7.733738967671539,"['JUN', 'PRKCH', 'IGFBP5', 'RXFP2', 'ACTB', 'ACTG1', 'RGS4', 'GNG3', 'ACTC1', 'MAFF', 'CRH', 'CALM3', 'CALM1', 'YWHAG', 'YWHAH']",0.4270696113725239,0,0,15
17,7-oxo-C and 7beta-HC pathways WP5064,0.018528996877556613,3.69431643625192,14.73447955814476,"['HSD11B1', 'HSD11B2', 'ACOX2', 'THEM5', 'ACOT6']",0.4270696113725239,0,0,5
18,Thyroxine (Thyroid Hormone) Production WP1981,0.020374477744990578,15.489278752436647,60.30707703123874,"['TPO', 'CGA']",0.4270696113725239,0,0,2
19,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.021633600616731825,3.5261707988980717,13.517602517163116,"['RAB3A', 'RAB25', 'HSPB1', 'NEFL', 'RABAC1']",0.4270696113725239,0,0,5
20,Monoamine GPCRs WP58,0.021633600616731825,3.5261707988980717,13.517602517163116,"['CHRM5', 'HTR1D', 'HTR2B', 'ADRA1D', 'DRD3']",0.4270696113725239,0,0,5
21,"GPCRs, Other WP117",0.02326307968363277,2.485333333333333,9.347059658405438,"['GPR183', 'F2R', 'GNRHR', 'ADRA1D', 'OR10A2', 'GPR83', 'DRD3', 'GPR18']",0.4270696113725239,0,0,8
22,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.023484761936146438,1.911138793729887,7.1694527529070955,"['TPH1', 'JUN', 'TSPYL1', 'BDNF', 'SSTR1', 'NEUROD1', 'ADCYAP1', 'KCNQ1', 'HES1', 'ALDOA', 'GAPDH', 'YWHAG', 'YWHAH', 'NKX3-1']",0.4270696113725239,0,0,14
23,Inflammatory Response Pathway WP453,0.025227308854679546,4.13515625,15.216664524404651,"['ZAP70', 'IL5', 'CD80', 'FN1']",0.4270696113725239,0,0,4
24,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.02528843087718043,2.2924596599044387,8.430310101460156,"['FZD1', 'SFRP4', 'WNT6', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'DKK1', 'CXXC4']",0.4270696113725239,0,0,9
25,Computational Model of Aerobic Glycolysis WP4629,0.025538622301667716,5.811951219512195,21.31569941603349,"['TPI1', 'ALDOA', 'GAPDH']",0.4270696113725239,0,0,3
26,Fas ligand pathway and stress induction of heat shock proteins WP314,0.02579615102250144,2.9101027397260273,10.643788025200623,"['JUN', 'CASP8', 'HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.4270696113725239,0,0,6
27,Vitamin A and carotenoid metabolism WP716,0.02579615102250144,2.9101027397260273,10.643788025200623,"['RBP4', 'RBP2', 'NPC1L1', 'ALDH1A1', 'LPL', 'BCO1']",0.4270696113725239,0,0,6
28,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.027585187346100812,2.587659157688541,9.290928983444099,"['NFKBIA', 'ZAP70', 'JUN', 'IL5', 'NFATC2', 'CALM1', 'MAPK3']",0.44037781227525225,0,0,7
29,Spinal Cord Injury WP2431,0.02894699448079474,2.03574940300604,7.211212509259698,"['SELP', 'NR4A1', 'CDKN1B', 'BDNF', 'MIF', 'PDYN', 'LILRB3', 'NTN1', 'TNFSF13B', 'RHOB', 'MAPK3']",0.44618298389362926,0,0,11
30,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.030058474359491855,3.87646484375,13.585499972355413,"['H2AFX', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.4478712679564286,0,0,4
31,Drug Induction of Bile Acid Pathway WP2289,0.03254446773114431,5.1658536585365855,17.693812742827408,"['ABCB1', 'SLC51A', 'ABCB11']",0.44903023977304746,0,0,3
32,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.03289950795980427,3.1024437927663735,10.592666324271061,"['NFKBIA', 'HSP90AA1', 'CASP8', 'IL18', 'PRDM1']",0.44903023977304746,0,0,5
33,Breast cancer pathway WP4262,0.033149883473178,1.8148915187376726,6.18282011579179,"['SHC4', 'FZD1', 'JUN', 'FGF1', 'FGF17', 'SFRP4', 'WNT6', 'FRAT1', 'FRAT2', 'RAD51', 'HEY1', 'HES1', 'FGF10', 'MAPK3']",0.44903023977304746,0,0,14
34,Cardiac Progenitor Differentiation WP2406,0.03733232002401525,2.9829310474471766,9.80756657873871,"['MESP1', 'ACTC1', 'THY1', 'DKK1', 'NODAL']",0.4885818113299019,0,0,5
35,Apoptosis Modulation and Signaling WP1772,0.040276052432512366,2.0863738227410544,6.701429003019947,"['NFKBIA', 'JUN', 'CASP8', 'ENDOG', 'BIK', 'PEA15', 'CYCS', 'MAPK3', 'HSPA1A']",0.4885818113299019,0,0,9
36,Development and heterogeneity of the ILC family WP3893,0.040441894897553406,4.648975609756097,14.913397854234264,"['IL5', 'IL7', 'IL18']",0.4885818113299019,0,0,3
37,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.040441894897553406,4.648975609756097,14.913397854234264,"['JUN', 'TIFA', 'TLR9']",0.4885818113299019,0,0,3
38,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.04637853207243004,2.0256432137218927,6.220585417258359,"['FZD1', 'SFRP4', 'WNT6', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'DKK1', 'CXXC4']",0.49992326158906236,0,0,9
39,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.046953255660442866,7.743664717348928,23.684794064756332,"['IL5', 'CD80']",0.49992326158906236,0,0,2
40,Fatty Acid Omega Oxidation WP206,0.046953255660442866,7.743664717348928,23.684794064756332,"['CYP2A6', 'ALDH1A1']",0.49992326158906236,0,0,2
41,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.046953255660442866,7.743664717348928,23.684794064756332,"['WNT6', 'ABCB1']",0.49992326158906236,0,0,2
42,VEGFA-VEGFR2 Signaling Pathway WP3888,0.047154319194585154,1.3992735416211493,4.2738426927986035,"['NCF2', 'HSPB1', 'FOXO4', 'ELK1', 'FUT1', 'APOLD1', 'ACTG1', 'TUBB8', 'ADAMTS1', 'DNAJB9', 'SH3BGRL3', 'CHAC1', 'IER5', 'TMSB10', 'MAPK3', 'DUSP5', 'JUN', 'HSP90AA1', 'EGR3', 'FN1', 'NFATC2', 'DKK1', 'SELE', 'NFKBIA', 'NR4A1', 'RCN1', 'NR4A3', 'CYCS', 'ALDOA', 'DSC1', 'GAPDH', 'FJX1', 'HSPA1A']",0.49992326158906236,0,0,33
43,Complement and Coagulation Cascades WP558,0.04865390361373302,2.449685858481821,7.405457268271499,"['THBD', 'SERPIND1', 'F2R', 'MASP2', 'PLG', 'CLU']",0.49992326158906236,0,0,6
44,ID signaling pathway WP53,0.04920944856805089,4.226075388026608,12.727542899601227,"['PAX8', 'ELK1', 'PAX2']",0.49992326158906236,0,0,3
45,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.05449150427048958,3.100390625,9.021239076323223,"['NFKBIA', 'ZAP70', 'NFATC2', 'CALM1']",0.5245280239427076,0,0,4
46,Oxysterols derived from cholesterol WP4545,0.05857706410368296,2.58455522971652,7.333448169651267,"['CYP39A1', 'ACOX2', 'GPR183', 'THEM5', 'ACOT6']",0.5245280239427076,0,0,5
47,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.05857706410368296,2.58455522971652,7.333448169651267,"['CREB3L1', 'HSD3B1', 'CALM3', 'REN', 'CALM1']",0.5245280239427076,0,0,5
48,Dopaminergic Neurogenesis WP2855,0.058818171531672486,3.8736585365853657,10.975253900405674,"['NEUROD1', 'ALDH1A1', 'SLC18A2']",0.5245280239427076,0,0,3
49,Hypertrophy Model WP516,0.058818171531672486,3.8736585365853657,10.975253900405674,"['NR4A3', 'MSTN', 'IL18']",0.5245280239427076,0,0,3
50,AGE/RAGE pathway WP2324,0.060712624959263384,2.1298035374776747,5.966865285789088,"['NFKBIA', 'JUN', 'CASP8', 'ALPL', 'CYCS', 'FOXO4', 'MAPK3']",0.5245280239427076,0,0,7
51,Selenium Micronutrient Network WP15,0.06111794691339866,2.0027830487033524,5.59767793273954,"['SELENOM', 'GPX4', 'GPX3', 'SELENOV', 'SAA2', 'PLG', 'KMO', 'SEPHS2']",0.5245280239427076,0,0,8
52,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.06313344315943427,6.194541910331384,17.112450815247072,"['HEY1', 'HES1']",0.5245280239427076,0,0,2
53,Circadian rhythm related genes WP3594,0.06425472417288601,1.574623505278431,4.322184106762831,"['KLF10', 'NTRK1', 'TPH1', 'JUN', 'EGR3', 'HOMER1', 'CARTPT', 'HCRTR2', 'RELB', 'HCRTR1', 'PER2', 'UBC', 'CRH', 'UTS2', 'GHRL', 'DRD3']",0.5245280239427076,0,0,16
54,Differentiation Pathway WP2848,0.06477386082697231,2.501024816321382,6.844937620026994,"['TPO', 'FGF1', 'DKK1', 'NODAL', 'FGF10']",0.5245280239427076,0,0,5
55,NRF2 pathway WP2884,0.06695126708926856,1.7433828988822668,4.713741738268879,"['DNAJB1', 'HSP90AA1', 'CYP2A6', 'HSP90AB1', 'SRXN1', 'GPX3', 'GSTP1', 'MAFF', 'SLC5A2', 'SLC5A3', 'HSPA1A']",0.5245280239427076,0,0,11
56,MAPK Signaling Pathway WP382,0.06771204160647772,1.481859410430839,3.9898934929427043,"['DUSP4', 'NTRK1', 'HSPA8', 'JUN', 'DUSP2', 'BDNF', 'HSPB1', 'FGF1', 'ELK1', 'DUSP6', 'RELB', 'FGF17', 'NR4A1', 'PTPN7', 'FGFR4', 'HSPA1B', 'HSPA1A', 'FGF10', 'CACNG5', 'MAPK3']",0.5245280239427076,0,0,20
57,Nuclear Receptors Meta-Pathway WP2882,0.06801589832677257,1.4654859926701431,3.939246575242201,"['JUN', 'HSP90AA1', 'ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'GPX3', 'ABCB4', 'TSC22D3', 'GSTP1', 'AMIGO2', 'SLC5A2', 'ABCB11', 'SLC5A3', 'THBD', 'DNAJB1', 'CYP2A6', 'B3GNT5', 'MAFF', 'HES1', 'HSPA1A']",0.5245280239427076,0,0,21
58,Cancer immunotherapy by PD-1 blockade WP4585,0.06923300539735962,3.5754596622889308,9.547469751009983,"['ZAP70', 'JUN', 'NFATC2']",0.5245280239427076,0,0,3
59,MAPK pathway in congenital thyroid cancer WP4928,0.06923300539735962,3.5754596622889308,9.547469751009983,"['JUN', 'ELK1', 'MAPK3']",0.5245280239427076,0,0,3
60,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.07132291213794319,2.422715053763441,6.397270326373649,"['NFKBIA', 'JUN', 'CASP8', 'RELB', 'MAPK3']",0.529143238820303,0,0,5
61,IL-18 signaling pathway WP4754,0.07220970373162972,1.48515122689762,3.903246001112886,"['SLC12A3', 'JUN', 'CD81', 'NCF2', 'MEPCE', 'FN1', 'IL18', 'HSPB1', 'FUT1', 'NFKBIA', 'NR4A1', 'CASP8', 'FAM186B', 'CYCS', 'PTPN7', 'NFKBIE', 'ITM2C', 'MYH7', 'MAPK3']",0.529143238820303,0,0,19
62,Hematopoietic Stem Cell Differentiation WP2849,0.07822091121182756,2.3491513374211324,5.98615033440519,"['TPO', 'TRAF3IP3', 'IL5', 'RHOH', 'NFATC2']",0.5391229952076662,0,0,5
63,BMP Signaling Pathway in Eyelid Development WP3927,0.08041402435363701,3.3198606271777003,8.367930098195842,"['JUN', 'MAPK3', 'FGF10']",0.5391229952076662,0,0,3
64,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.08041402435363701,3.3198606271777003,8.367930098195842,"['TNC', 'FN1', 'MAPK3']",0.5391229952076662,0,0,3
65,Canonical NF-KB pathway WP4562,0.08086533519996568,5.161793372319688,12.981755664641966,"['NFKBIA', 'NFKBIE']",0.5391229952076662,0,0,2
66,HIF1A and PPARG regulation of glycolysis WP2456,0.08086533519996568,5.161793372319688,12.981755664641966,"['TPI1', 'GAPDH']",0.5391229952076662,0,0,2
67,NAD Biosynthesis II (from tryptophan) WP2485,0.08086533519996568,5.161793372319688,12.981755664641966,"['HAAO', 'KMO']",0.5391229952076662,0,0,2
68,Wnt signaling WP428,0.0820142364074302,1.724950884086444,4.313864863164642,"['FZD1', 'SFRP4', 'WNT6', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'NFATC2', 'DKK1', 'CXXC4']",0.5391229952076662,0,0,10
69,Aryl Hydrocarbon Receptor Pathway WP2873,0.08696847510959914,2.5830078125,6.308246427630236,"['HSP90AA1', 'JUN', 'CDKN1B', 'HES1']",0.5579640027373499,0,0,4
70,Pathogenic Escherichia coli infection WP2272,0.08737691318034561,2.067710371819961,5.04009403365387,"['TUBB8', 'TUBB6', 'TUBB2A', 'ACTB', 'TUBA4A', 'ACTG1']",0.5579640027373499,0,0,6
71,Apoptosis Modulation by HSP70 WP384,0.09231751849305958,3.0983414634146342,7.381864704739444,"['CASP8', 'CYCS', 'HSPA1A']",0.5652867228273648,0,0,3
72,Kynurenine Pathway and links to Cellular Senescence WP5044,0.09231751849305958,3.0983414634146342,7.381864704739444,"['HAAO', 'KMO', 'ACMSD']",0.5652867228273648,0,0,3
73,Nanomaterial induced apoptosis WP2507,0.09231751849305958,3.0983414634146342,7.381864704739444,"['ENDOG', 'CASP8', 'CYCS']",0.5652867228273648,0,0,3
74,Alzheimer's disease WP2059,0.09483703350729729,1.7988064791133844,4.2372600827604865,"['CASP8', 'LPL', 'CYCS', 'CALM3', 'CALM1', 'GAPDH', 'MAPK3', 'CDK5R1']",0.572866945645431,0,0,8
75,PTF1A related regulatory pathway WP4147,0.0999010881257506,4.424115845168477,10.191281336273146,"['HES1', 'FGF10']",0.5799452778209159,0,0,2
76,Role of Osx and miRNAs in tooth development WP3971,0.0999010881257506,4.424115845168477,10.191281336273146,"['ALPL', 'DKK1']",0.5799452778209159,0,0,2
77,Supression of HMGB1 mediated inflammation by THBD WP4479,0.0999010881257506,4.424115845168477,10.191281336273146,"['NFKBIA', 'THBD']",0.5799452778209159,0,0,2
78,Imatinib and Chronic Myeloid Leukemia WP3640,0.10489694172257856,2.904512195121951,6.549027056256545,"['SPRED2', 'ABCB1', 'CDKN1B']",0.5924075657937301,0,0,3
79,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.10489694172257856,2.904512195121951,6.549027056256545,"['HTR2B', 'ELK1', 'MAPK3']",0.5924075657937301,0,0,3
80,Prion disease pathway WP3995,0.10602372542169665,2.384014423076923,5.349948612991223,"['PRNP', 'HSPA5', 'ELK1', 'MAPK3']",0.5924075657937301,0,0,4
81,Corticotropin-releasing hormone signaling pathway WP2355,0.11198245360678014,1.723529411764706,3.7735178450959124,"['NFKBIA', 'NR4A1', 'HSP90AA1', 'HSD3B1', 'IL18', 'CRH', 'ELK1', 'MAPK3']",0.5960853999948675,0,0,8
82,Netrin-UNC5B signaling pathway WP4747,0.11774701359383231,2.039409373874569,4.362739016287854,"['JUN', 'ALPL', 'NTN1', 'SELE', 'MAPK3']",0.5960853999948675,0,0,5
83,"COVID-19, thrombosis and anticoagulation WP4927",0.11781122141822371,15.475170399221032,33.09630982242314,['PLG'],0.5960853999948675,0,0,1
84,Nicotine Metabolism WP1600,0.11781122141822371,15.475170399221032,33.09630982242314,['CYP2A6'],0.5960853999948675,0,0,1
85,Globo Sphingolipid Metabolism WP1424,0.11810373814221646,2.733486370157819,5.839251453440813,"['ST6GALNAC1', 'FUT2', 'FUT1']",0.5960853999948675,0,0,3
86,Calcium Regulation in the Cardiac Cell WP536,0.119257208836841,1.5144036873439601,3.2203380972784355,"['RGS4', 'GJD2', 'GNG3', 'PRKCH', 'PLN', 'CHRM5', 'GJB5', 'CALM3', 'ADRA1D', 'CALM1', 'YWHAG', 'YWHAH']",0.5960853999948675,0,0,12
87,ACE Inhibitor Pathway WP554,0.12001719462983909,3.870857699805068,8.206683824738835,"['ATP6AP2', 'REN']",0.5960853999948675,0,0,2
88,Cytokines and Inflammatory Response WP530,0.12001719462983909,3.870857699805068,8.206683824738835,"['IL5', 'IL7']",0.5960853999948675,0,0,2
89,EDA signaling in hair follicle development WP3930,0.12001719462983909,3.870857699805068,8.206683824738835,"['DKK1', 'RELB']",0.5960853999948675,0,0,2
90,Gene regulatory network modelling somitogenesis  WP2854,0.12001719462983909,3.870857699805068,8.206683824738835,"['HES1', 'TBX6']",0.5960853999948675,0,0,2
91,Mitochondrial CIV Assembly WP4922,0.1267840451535868,2.2134486607142856,4.5713692743512055,"['COA3', 'PET100', 'SCO2', 'HIGD1A']",0.6227743756445417,0,0,4
92,IL-7 signaling pathway WP205,0.1318880592169417,2.5814634146341464,5.22953310916676,"['CDKN1B', 'IL7', 'MAPK3']",0.6271698135103504,0,0,3
93,Pregnane X receptor pathway WP2876,0.1318880592169417,2.5814634146341464,5.22953310916676,"['HSP90AA1', 'CYP2A6', 'ABCB1']",0.6271698135103504,0,0,3
94,Purinergic signaling WP4900,0.1318880592169417,2.5814634146341464,5.22953310916676,"['P2RY12', 'LPAR6', 'P2RY14']",0.6271698135103504,0,0,3
95,CAMKK2  Pathway WP4874,0.1377546824530083,2.136988146551724,4.236110656352089,"['WFS1', 'NFATC2', 'CALM1', 'MAPK3']",0.6431894222312289,0,0,4
96,Farnesoid X receptor pathway WP2879,0.14101244603727164,3.4405458089668617,6.739709691269648,"['ABCB4', 'ABCB11']",0.6431894222312289,0,0,2
97,Neuroinflammation WP4919,0.14101244603727164,3.4405458089668617,6.739709691269648,"['NFKBIA', 'JUN']",0.6431894222312289,0,0,2
98,Sulfation Biotransformation Reaction WP692,0.14101244603727164,3.4405458089668617,6.739709691269648,"['SULT1C2', 'SULT1C4']",0.6431894222312289,0,0,2
99,Constitutive Androstane Receptor Pathway WP2875,0.14619938322411652,2.4454428754813864,4.702058312567882,"['HSP90AA1', 'CYP2A6', 'ABCB1']",0.6535112430118009,0,0,3
100,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.14619938322411652,2.4454428754813864,4.702058312567882,"['JUN', 'SRXN1', 'GSTP1']",0.6535112430118009,0,0,3
101,Prolactin Signaling Pathway WP2037,0.1539788326323583,1.6441990917994835,3.0761980731703766,"['NFKBIA', 'ZAP70', 'JUN', 'ELK1', 'PRLR', 'YWHAG', 'MAPK3']",0.6788500391373845,0,0,7
102,Exercise-induced Circadian Regulation WP410,0.1549053780581951,1.8447144253595866,3.44028321946842,"['PER2', 'HSPA8', 'RBPMS', 'GSTP1', 'G0S2']",0.6788500391373845,0,0,5
103,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.16098704716830525,2.3230243902439023,4.242844618698792,"['BDNF', 'CGA', 'MAPK3']",0.6861283524163501,0,0,3
104,Genes targeted by miRNAs in adipocytes WP1992,0.16270605225085705,3.096296296296296,5.622285984026813,"['KCNE1', 'KCNQ1']",0.6861283524163501,0,0,2
105,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.16270605225085705,3.096296296296296,5.622285984026813,"['JUN', 'MAPK3']",0.6861283524163501,0,0,2
106,Platelet-mediated interactions with vascular and circulating cells WP4462,0.16270605225085705,3.096296296296296,5.622285984026813,"['SELP', 'SELE']",0.6861283524163501,0,0,2
107,Glucocorticoid Receptor Pathway WP2880,0.16444545048771897,1.690695605764099,3.0520037593438376,"['THBD', 'HSP90AA1', 'JUN', 'TSC22D3', 'B3GNT5', 'AMIGO2']",0.6869823959627138,0,0,6
108,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.17620070074273791,2.2122648083623693,3.8407828159567203,"['ABCB1', 'ABCB4', 'ABCB11']",0.7292751225185542,0,0,3
109,Glutathione metabolism WP100,0.18493590720156172,2.8146376041112884,4.750393249396035,"['GPX4', 'GPX3']",0.7405084994004246,0,0,2
110,Major receptors targeted by epinephrine and norepinephrine WP4589,0.18493590720156172,2.8146376041112884,4.750393249396035,"['ADCY10', 'ADRA1D']",0.7405084994004246,0,0,2
111,IL-5 signaling pathway WP127,0.18506594133515597,1.8774857954545454,3.16739941482153,"['SPRED1', 'JUN', 'ELK1', 'MAPK3']",0.7405084994004246,0,0,4
112,Allograft Rejection WP2328,0.185541279491829,1.721407624633431,2.89967308464237,"['CASP8', 'ABCB1', 'IL5', 'CD80', 'HLA-DQB1']",0.7405084994004246,0,0,5
113,Ovarian infertility WP34,0.1917906904018884,2.1115742793791576,3.4869495709417677,"['CDKN1B', 'MSH5', 'PRLR']",0.7520213913126677,0,0,3
114,Striated Muscle Contraction Pathway WP383,0.1917906904018884,2.1115742793791576,3.4869495709417677,"['MYOM1', 'ACTC1', 'ACTG1']",0.7520213913126677,0,0,3
115,ATM Signaling Pathway WP2516,0.19763594703217607,1.8221507352941178,2.954305086128943,"['NFKBIA', 'JUN', 'RAD51', 'H2AFX']",0.7682023332468062,0,0,4
116,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.20135931153215206,1.575674151713158,2.5252767858346226,"['MYO1E', 'CDKN1B', 'KIRREL2', 'CD80', 'DKK1', 'PAX2']",0.7759276918523446,0,0,6
117,16p11.2 distal deletion syndrome WP4950,0.20770838169678726,2.0196394485683986,3.1741061421530334,"['PLN', 'CD81', 'NFATC2']",0.7769298075518766,0,0,3
118,PDGF Pathway WP2526,0.21045567738404009,1.7699776785714285,2.758475178488831,"['NFKBIA', 'JUN', 'ELK1', 'MAPK3']",0.7769298075518766,0,0,4
119,Acute viral myocarditis WP4298,0.21103008594437825,1.5493150684931507,2.4103539954769673,"['CASP8', 'ENDOG', 'CD80', 'CYCS', 'ACTB', 'MAPK3']",0.7769298075518766,0,0,6
120,Regulation of Actin Cytoskeleton WP51,0.21756739639471098,1.3428177672481205,2.0481282446187783,"['FGF17', 'VIL1', 'CHRM5', 'F2R', 'FN1', 'FGF1', 'FGFR4', 'ACTB', 'ACTG1', 'FGF10', 'MAPK3']",0.7769298075518766,0,0,11
121,Modulators of TCR signaling and T cell activation WP5072,0.21815531748839373,1.613514173998045,2.456652785583807,"['NFKBIA', 'ZAP70', 'CDKN1B', 'RHOH', 'ELOB']",0.7769298075518766,0,0,5
122,COVID-19 adverse outcome pathway WP4891,0.22175499745406346,5.1577409931840315,7.768497271845214,['IL7'],0.7769298075518766,0,0,1
123,Steroid Biosynthesis WP496,0.22175499745406346,5.1577409931840315,7.768497271845214,['HSD3B1'],0.7769298075518766,0,0,1
124,Common Pathways Underlying Drug Addiction WP2636,0.22350137169445033,1.720703125,2.578194410207365,"['CALM1', 'ACTB', 'ACTG1', 'MAPK3']",0.7769298075518766,0,0,4
125,NO/cGMP/PKG mediated Neuroprotection WP4008,0.22350137169445033,1.720703125,2.578194410207365,"['NFKBIA', 'NEFL', 'CYCS', 'CALM1']",0.7769298075518766,0,0,4
126,Prader-Willi and Angelman Syndrome WP3998,0.22940075370537258,1.5804855666606819,2.3269248586198237,"['CDKN2C', 'BDNF', 'GHRL', 'CGA', 'TYR']",0.7769298075518766,0,0,5
127,Blood Clotting Cascade WP272,0.2304398887443909,2.381316539211276,3.4952136343438562,"['F8A1', 'PLG']",0.7769298075518766,0,0,2
128,ERK Pathway in Huntington's Disease WP3853,0.2304398887443909,2.381316539211276,3.4952136343438562,"['BDNF', 'ELK1']",0.7769298075518766,0,0,2
129,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2304398887443909,2.381316539211276,3.4952136343438562,"['CD81', 'HSPB1']",0.7769298075518766,0,0,2
130,miRNAs involved in DNA damage response WP1545,0.2304398887443909,2.381316539211276,3.4952136343438562,"['CDKN1B', 'H2AFX']",0.7769298075518766,0,0,2
131,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.2304398887443909,2.381316539211276,3.4952136343438562,"['FZD1', 'SFRP4']",0.7769298075518766,0,0,2
132,Tryptophan catabolism leading to NAD+ production WP4210,0.2304398887443909,2.381316539211276,3.4952136343438562,"['HAAO', 'KMO']",0.7769298075518766,0,0,2
133,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.23116703446174405,1.3218311952619424,1.9359734482193705,"['SHC4', 'NFKBIA', 'NTRK1', 'JUN', 'RAB3A', 'NCF2', 'BDNF', 'ALPL', 'ELK1', 'MAPK3', 'CDK5R1']",0.7769298075518766,0,0,11
134,Metabolic reprogramming in colon cancer WP4290,0.23674936199752697,1.6740920608108107,2.4119535636108096,"['HK3', 'PGAM1', 'SLC16A3', 'GAPDH']",0.7857061210092626,0,0,4
135,PDGFR-beta pathway WP3972,0.2403389821562234,1.8578341463414634,2.648723295103684,"['JUN', 'ELK1', 'MAPK3']",0.7857061210092626,0,0,3
136,Endochondral Ossification with Skeletal Dysplasias WP4808,0.2408092585643601,1.5487781036168133,2.205073006384929,"['ADAMTS1', 'MGP', 'ALPL', 'CALM1', 'BMP6']",0.7857061210092626,0,0,5
137,Endochondral Ossification WP474,0.2408092585643601,1.5487781036168133,2.205073006384929,"['ADAMTS1', 'MGP', 'ALPL', 'CALM1', 'BMP6']",0.7857061210092626,0,0,5
138,NOTCH1 regulation of endothelial cell calcification WP3413,0.25346944572073543,2.2110832637148428,3.0347382967854193,"['MGP', 'ALPL']",0.8186420238692605,0,0,2
139,Heart Development WP1591,0.2569618854462885,1.786266416510319,2.427227948268309,"['HEY1', 'NFATC2', 'FGF10']",0.8186420238692605,0,0,3
140,Regulation of Microtubule Cytoskeleton WP2038,0.2637586596374829,1.5880408653846154,2.1164150321740878,"['SPRED1', 'PARD6A', 'RHO', 'PHLDB2']",0.8186420238692605,0,0,4
141,3q29 copy number variation syndrome WP4906,0.26405752002755684,1.489021730957215,1.9827639461749698,"['TM4SF19', 'JUN', 'SLC51A', 'DYNLL1', 'DYNLL2']",0.8186420238692605,0,0,5
142,Composition of Lipid Particles WP3601,0.2690439661232049,3.868062317429406,5.078303472903129,['LPL'],0.8186420238692605,0,0,1
143,Hfe effect on hepcidin production WP3924,0.2690439661232049,3.868062317429406,5.078303472903129,['BMP6'],0.8186420238692605,0,0,1
144,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.2690439661232049,3.868062317429406,5.078303472903129,['REN'],0.8186420238692605,0,0,1
145,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.2690439661232049,3.868062317429406,5.078303472903129,['MAPK3'],0.8186420238692605,0,0,1
146,ESC Pluripotency Pathways WP3931,0.2705860624875202,1.3325743200506008,1.7418946050565194,"['FZD1', 'FGF17', 'WNT6', 'JUN', 'FGF1', 'FGFR4', 'ELK1', 'FGF10']",0.8186420238692605,0,0,8
147,Complement system WP2806,0.2720365327315893,1.4079345312222025,1.83287579705727,"['SELP', 'PRNP', 'SELL', 'MASP2', 'PLG', 'SELE']",0.8186420238692605,0,0,6
148,Toll-like Receptor Signaling Pathway WP75,0.2720365327315893,1.4079345312222025,1.83287579705727,"['NFKBIA', 'JUN', 'CASP8', 'CD80', 'TLR9', 'MAPK3']",0.8186420238692605,0,0,6
149,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2737327919557797,1.72,2.228436919651903,"['LPL', 'FOXO4', 'PRDM1']",0.8186420238692605,0,0,3
150,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.2765435024703766,2.0635477582846002,2.652457746676863,"['ALPL', 'PHEX']",0.8186420238692605,0,0,2
151,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.2765435024703766,2.0635477582846002,2.652457746676863,"['JUN', 'MAPK3']",0.8186420238692605,0,0,2
152,TNF-alpha signaling pathway WP231,0.28637640558147315,1.3384481445206224,1.673660113310171,"['NFKBIA', 'HSP90AA1', 'JUN', 'CASP8', 'NFKBIE', 'SELE', 'MAPK3']",0.8369159366603529,0,0,7
153,Osteoblast differentiation WP4787,0.28833345468835425,1.3043550051599586,1.6221449801227832,"['FZD1', 'WNT6', 'PRKCH', 'HEY1', 'FGF1', 'FGFR4', 'FGF10', 'MAPK3']",0.8369159366603529,0,0,8
154,Regulation of toll-like receptor signaling pathway WP1449,0.28833345468835425,1.3043550051599586,1.6221449801227832,"['NFKBIA', 'JUN', 'CASP8', 'CD80', 'PELI3', 'TIFA', 'TLR9', 'MAPK3']",0.8369159366603529,0,0,8
155,PI3K-Akt signaling pathway WP4172,0.291667804961284,1.1688376044173865,1.4401713070979603,"['NTRK1', 'HSP90AA1', 'CDKN1B', 'HSP90AB1', 'ANGPT2', 'BDNF', 'F2R', 'FN1', 'TNC', 'FGF1', 'PRLR', 'FGF17', 'GNG3', 'LPAR6', 'IL7', 'CREB3L1', 'FGFR4', 'FGF10', 'MAPK3']",0.8411323149528642,0,0,19
156,IL1 and megakaryocytes in obesity WP2865,0.2995717495512345,1.9344541910331383,2.331793646324564,"['F2R', 'IL18']",0.8529208410789925,0,0,2
157,Nicotine Activity on Dopaminergic Neurons WP1602,0.2995717495512345,1.9344541910331383,2.331793646324564,"['DRD3', 'SLC18A2']",0.8529208410789925,0,0,2
158,Gastrin signaling pathway WP4659,0.30636061374905915,1.2772993733575904,1.5110354442886376,"['NFKBIA', 'CHGA', 'JUN', 'PRKCH', 'CDKN1B', 'ELK1', 'RHOB', 'MAPK3']",0.8533475704461286,0,0,8
159,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.30755892263867673,1.6011774600504625,1.8879300765205123,"['HEXIM1', 'NFKBIA', 'NFATC2']",0.8533475704461286,0,0,3
160,miRNA regulation of prostate cancer signaling pathways WP3981,0.30755892263867673,1.6011774600504625,1.8879300765205123,"['NFKBIA', 'CDKN1B', 'CREB3L1']",0.8533475704461286,0,0,3
161,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.3134621091831304,3.094255111976631,3.589573537939269,['GSTP1'],0.8533475704461286,0,0,1
162,Codeine and Morphine Metabolism WP1604,0.3134621091831304,3.094255111976631,3.589573537939269,['ABCB1'],0.8533475704461286,0,0,1
163,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.3134621091831304,3.094255111976631,3.589573537939269,['CYP2C18'],0.8533475704461286,0,0,1
164,FOXP3 in COVID-19 WP5063,0.3134621091831304,3.094255111976631,3.589573537939269,['CD80'],0.8533475704461286,0,0,1
165,Ebstein-Barr virus LMP1 signaling WP262,0.3224746658443112,1.8205481022818484,2.060370180643169,"['NFKBIA', 'HSP90AA1']",0.8533475704461286,0,0,2
166,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.3224746658443112,1.8205481022818484,2.060370180643169,"['ELK1', 'MAPK3']",0.8533475704461286,0,0,2
167,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.3224746658443112,1.8205481022818484,2.060370180643169,"['NFKBIA', 'NFKBIE']",0.8533475704461286,0,0,2
168,Amyotrophic lateral sclerosis (ALS) WP2447,0.3245393444649706,1.5477073170731708,1.7417101135306696,"['NEFL', 'NEFM', 'NEFH']",0.8533475704461286,0,0,3
169,Disruption of postsynaptic signaling by CNV WP4875,0.3245393444649706,1.5477073170731708,1.7417101135306696,"['HOMER1', 'YWHAG', 'MAPK3']",0.8533475704461286,0,0,3
170,MAPK Cascade WP422,0.3245393444649706,1.5477073170731708,1.7417101135306696,"['JUN', 'ELK1', 'MAPK3']",0.8533475704461286,0,0,3
171,Folate Metabolism WP176,0.33322612904836374,1.4071377840909092,1.5463514878406124,"['GPX4', 'GPX3', 'SAA2', 'PLG']",0.8675794878834362,0,0,4
172,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3362220301568807,1.3344793878720465,1.4545605581959655,"['NFKBIA', 'ANGPT2', 'RAD51', 'FN1', 'MAPK3']",0.8675794878834362,0,0,5
173,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3415182421934803,1.4976868607395752,1.609046144490459,"['JUN', 'ELK1', 'MAPK3']",0.8675794878834362,0,0,3
174,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.34518254319118136,1.719298245614035,1.8287864093996173,"['SELE', 'RELB']",0.8675794878834362,0,0,2
175,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.34518254319118136,1.719298245614035,1.8287864093996173,"['HK3', 'CD80']",0.8675794878834362,0,0,2
176,Copper homeostasis WP3286,0.3472825625244283,1.37578125,1.4550489905297423,"['PRNP', 'JUN', 'STEAP4', 'SCO2']",0.8675794878834362,0,0,4
177,DNA damage response WP707,0.3484564119385792,1.3117782527295923,1.3829318991808588,"['CDKN1B', 'CASP8', 'RAD51', 'H2AFX', 'CYCS']",0.8675794878834362,0,0,5
178,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3484564119385792,1.3117782527295923,1.3829318991808588,"['JUN', 'CDKN1B', 'PAX8', 'CGA', 'MAPK3']",0.8675794878834362,0,0,5
179,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.35518354873080277,2.578383641674781,2.668937982098586,['DHCR24'],0.8675794878834362,0,0,1
180,Dual hijack model of Vif in HIV infection WP3300,0.35518354873080277,2.578383641674781,2.668937982098586,['ELOB'],0.8675794878834362,0,0,1
181,Nucleotide GPCRs WP80,0.35518354873080277,2.578383641674781,2.668937982098586,['LPAR6'],0.8675794878834362,0,0,1
182,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.35518354873080277,2.578383641674781,2.668937982098586,['NFKBIA'],0.8675794878834362,0,0,1
183,Tgif disruption of Shh signaling WP3674,0.35518354873080277,2.578383641674781,2.668937982098586,['NODAL'],0.8675794878834362,0,0,1
184,miRNA regulation of DNA damage response WP1530,0.3729837126528482,1.268608880983286,1.2511281180207006,"['CDKN1B', 'CASP8', 'RAD51', 'H2AFX', 'CYCS']",0.8903243420253474,0,0,5
185,Hepatitis B infection WP4666,0.3750094455333321,1.170821616183274,1.1483466008234868,"['JUN', 'EGR3', 'CASP8', 'ATP6AP1', 'CREB3L1', 'NFATC2', 'CYCS', 'ELK1', 'MAPK3']",0.8903243420253474,0,0,9
186,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.37534466588334103,1.406740576496674,1.378479954686944,"['PRKCH', 'HSD3B1', 'MAPK3']",0.8903243420253474,0,0,3
187,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.37540111762063116,1.3170711436170213,1.2904138576980813,"['CDKN1B', 'HSPA5', 'F2R', 'HSPB1']",0.8903243420253474,0,0,4
188,RANKL/RANK signaling pathway WP2018,0.37540111762063116,1.3170711436170213,1.2904138576980813,"['NFKBIA', 'JUN', 'RELB', 'MAPK3']",0.8903243420253474,0,0,4
189,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.3897781045402556,1.5471734892787525,1.4577123046994722,"['ACOX2', 'PTGES']",0.8903243420253474,0,0,2
190,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.3897781045402556,1.5471734892787525,1.4577123046994722,"['TRPA1', 'ACOX2']",0.8903243420253474,0,0,2
191,Estrogen signaling pathway WP712,0.3897781045402556,1.5471734892787525,1.4577123046994722,"['JUN', 'ELK1']",0.8903243420253474,0,0,2
192,Unfolded protein response WP4925,0.3897781045402556,1.5471734892787525,1.4577123046994722,"['CASP8', 'HSPA5']",0.8903243420253474,0,0,2
193,Pathways in clear cell renal cell carcinoma WP4018,0.39161137192589557,1.205962335120848,1.1305719966230825,"['LDHC', 'HK3', 'TPI1', 'ENO2', 'ALDOA', 'GAPDH']",0.8903243420253474,0,0,6
194,Oxidation by Cytochrome P450 WP43,0.39213396063952266,1.3652797704447632,1.278109061693925,"['CYP39A1', 'CYP2A6', 'CYP2C18']",0.8903243420253474,0,0,3
195,Oxidative Damage WP3941,0.39213396063952266,1.3652797704447632,1.278109061693925,"['CDKN1B', 'CYCS', 'NFKBIE']",0.8903243420253474,0,0,3
196,Vitamin D-sensitive calcium signaling in depression WP4698,0.39213396063952266,1.3652797704447632,1.278109061693925,"['TPH1', 'CALB1', 'GPX4']",0.8903243420253474,0,0,3
197,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3943718561991471,2.2099040200306024,2.056229542659949,['ELOB'],0.8903243420253474,0,0,1
198,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.3943718561991471,2.2099040200306024,2.056229542659949,['TIFA'],0.8903243420253474,0,0,1
199,16p11.2 proximal deletion syndrome WP4949,0.3975069775029347,1.2281804217288088,1.1330489948198348,"['CASP8', 'TBX6', 'ALDOA', 'YPEL3', 'MAPK3']",0.892892557506592,0,0,5
200,Ferroptosis WP4313,0.4088052139661224,1.3261881533101045,1.1862971664797863,"['PRNP', 'GPX4', 'CP']",0.9043702268020162,0,0,3
201,Prostaglandin Synthesis and Regulation WP98,0.4088052139661224,1.3261881533101045,1.1862971664797863,"['HSD11B1', 'HSD11B2', 'PTGES']",0.9043702268020162,0,0,3
202,Apoptosis WP254,0.4097377297873237,1.208913734115347,1.0786387812625975,"['NFKBIA', 'JUN', 'CASP8', 'CYCS', 'NFKBIE']",0.9043702268020162,0,0,5
203,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.411567722463015,1.4734057365636313,1.3080626463093408,"['ANGPT2', 'MAPK3']",0.9043702268020162,0,0,2
204,Glycogen Synthesis and Degradation WP500,0.425334336542343,1.2892682926829269,1.102169349422571,"['HK3', 'CALM3', 'CALM1']",0.9043702268020162,0,0,3
205,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.425334336542343,1.2892682926829269,1.102169349422571,"['NFKBIA', 'RELB', 'MAPK3']",0.9043702268020162,0,0,3
206,Estrogen Receptor Pathway WP2881,0.43118069053527847,1.9335443037974684,1.626551687164885,['JUN'],0.9043702268020162,0,0,1
207,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.43118069053527847,1.9335443037974684,1.626551687164885,['ALDH1A1'],0.9043702268020162,0,0,1
208,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.43118069053527847,1.9335443037974684,1.626551687164885,['TBX6'],0.9043702268020162,0,0,1
209,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.43118069053527847,1.9335443037974684,1.626551687164885,['ELK1'],0.9043702268020162,0,0,1
210,Tamoxifen metabolism WP691,0.43118069053527847,1.9335443037974684,1.626551687164885,['CYP2A6'],0.9043702268020162,0,0,1
211,Canonical and non-canonical Notch signaling WP3845,0.4329647170819496,1.4063441431862485,1.1772493309035834,"['HEY1', 'HES1']",0.9043702268020162,0,0,2
212,Gastric Cancer Network 1 WP2361,0.4329647170819496,1.4063441431862485,1.1772493309035834,"['SMOC2', 'GATD3A']",0.9043702268020162,0,0,2
213,miRNAs involvement in the immune response in sepsis WP4329,0.4329647170819496,1.4063441431862485,1.1772493309035834,"['NFKBIA', 'RELB']",0.9043702268020162,0,0,2
214,Physiological and pathological hypertrophy of the heart WP1528,0.4329647170819496,1.4063441431862485,1.1772493309035834,"['JUN', 'CALM1']",0.9043702268020162,0,0,2
215,Senescence and Autophagy in Cancer WP615,0.4355778009945329,1.1461187214611872,0.9525184686422745,"['JUN', 'CDKN1B', 'IGFBP5', 'FKBP8', 'FN1', 'GABARAP']",0.9055966374165405,0,0,6
216,Aryl Hydrocarbon Receptor Netpath WP2586,0.441699165600121,1.2543441001977587,1.0249574901094913,"['HSP90AA1', 'CDKN1B', 'LPL']",0.9140718843669172,0,0,3
217,Cell migration and invasion through p75NTR WP4561,0.4539363634187056,1.3451139927112468,1.062368690200612,"['JUN', 'BDNF']",0.9164945453268316,0,0,2
218,Photodynamic therapy-induced unfolded protein response WP3613,0.4539363634187056,1.3451139927112468,1.062368690200612,"['HSPA5', 'DNAJB9']",0.9164945453268316,0,0,2
219,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.45787940686826156,1.2212580231065469,0.9539850126866537,"['ACTC1', 'ACTB', 'ACTG1']",0.9164945453268316,0,0,3
220,Dopamine metabolism WP2436,0.46575439852998873,1.7185978578383643,1.3131751676107994,['TYR'],0.9164945453268316,0,0,1
221,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.46575439852998873,1.7185978578383643,1.3131751676107994,['MAFF'],0.9164945453268316,0,0,1
222,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.46575439852998873,1.7185978578383643,1.3131751676107994,['FN1'],0.9164945453268316,0,0,1
223,Nanoparticle triggered regulated necrosis WP2513,0.46575439852998873,1.7185978578383643,1.3131751676107994,['CASP8'],0.9164945453268316,0,0,1
224,Selective expression of chemokine receptors during T-cell polarization WP4494,0.46575439852998873,1.7185978578383643,1.3131751676107994,['IL5'],0.9164945453268316,0,0,1
225,Valproic acid pathway WP3871,0.46575439852998873,1.7185978578383643,1.3131751676107994,['CYP2A6'],0.9164945453268316,0,0,1
226,Signal transduction through IL1R WP4496,0.47445535298016306,1.2889863547758285,0.9610524465176661,"['NFKBIA', 'JUN']",0.9164945453268316,0,0,2
227,Toll-like Receptor Signaling related to MyD88 WP3858,0.47445535298016306,1.2889863547758285,0.9610524465176661,"['TLR9', 'RELB']",0.9164945453268316,0,0,2
228,Small cell lung cancer WP4658,0.478947726323186,1.0919074479106712,0.8038227561668124,"['NFKBIA', 'CDKN1B', 'CASP8', 'CKS2', 'FN1', 'CYCS']",0.9164945453268316,0,0,6
229,T-cell receptor (TCR) signaling pathway WP69,0.48202112478551545,1.1048736210026533,0.8063006818178345,"['NFKBIA', 'ZAP70', 'JUN', 'NFATC2', 'MAPK3']",0.9164945453268316,0,0,5
230,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4855188451981688,1.1249289772727273,0.8128030063738931,"['JUN', 'PRKCH', 'RELB', 'MAPK3']",0.9164945453268316,0,0,4
231,Oncostatin M Signaling Pathway WP2374,0.4855188451981688,1.1249289772727273,0.8128030063738931,"['NFKBIA', 'CDKN1B', 'PRKCH', 'MAPK3']",0.9164945453268316,0,0,4
232,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.48961390753043116,1.1600487804878048,0.8284350810561514,"['HSP90AA1', 'JUN', 'ELK1']",0.9164945453268316,0,0,3
233,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.4903883770274144,1.0312252964426878,0.7348074178019839,"['HSP90AA1', 'CDKN1B', 'HSP90AB1', 'ANGPT2', 'F2R', 'FN1', 'TNC', 'FGF1', 'PRLR', 'FGF17', 'GNG3', 'LPAR6', 'CREB3L1', 'FGFR4', 'FGF10', 'MAPK3']",0.9164945453268316,0,0,16
234,Intraflagellar transport proteins binding to dynein WP4532,0.4944992576163163,1.2373489278752436,0.8713530296924689,"['DYNLL1', 'DYNLL2']",0.9164945453268316,0,0,2
235,Resistin as a regulator of inflammation WP4481,0.4944992576163163,1.2373489278752436,0.8713530296924689,"['NFKBIA', 'MAPK3']",0.9164945453268316,0,0,2
236,Biogenic Amine Synthesis WP550,0.498228578332036,1.5466407010710808,1.0775388764895348,['TPH1'],0.9164945453268316,0,0,1
237,Cells and molecules involved in local acute inflammatory response  WP4493,0.498228578332036,1.5466407010710808,1.0775388764895348,['SELP'],0.9164945453268316,0,0,1
238,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.498228578332036,1.5466407010710808,1.0775388764895348,['TPO'],0.9164945453268316,0,0,1
239,Glycolysis in senescence WP5049,0.498228578332036,1.5466407010710808,1.0775388764895348,['GAPDH'],0.9164945453268316,0,0,1
240,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.498228578332036,1.5466407010710808,1.0775388764895348,['IDI2'],0.9164945453268316,0,0,1
241,Osteoblast Signaling WP322,0.498228578332036,1.5466407010710808,1.0775388764895348,['BGLAP'],0.9164945453268316,0,0,1
242,Osteopontin Signaling WP1434,0.498228578332036,1.5466407010710808,1.0775388764895348,['MAPK3'],0.9164945453268316,0,0,1
243,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.498228578332036,1.5466407010710808,1.0775388764895348,['ZAP70'],0.9164945453268316,0,0,1
244,ATM Signaling Network in Development and Disease  WP3878,0.5051363311982917,1.131683521713266,0.7728571457136092,"['H2AFX', 'HSPB1', 'CDK5R1']",0.921616081818924,0,0,3
245,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5051363311982917,1.131683521713266,0.7728571457136092,"['CASP8', 'CXCL17', 'CXCL5']",0.921616081818924,0,0,3
246,Ras signaling WP4223,0.5098813747438526,1.031041257367387,0.6944858614262734,"['SHC4', 'NTRK1', 'ZAP70', 'GNG3', 'CALM3', 'FOXO4', 'CALM1', 'FGFR4', 'ELK1', 'MAPK3']",0.9228127186483662,0,0,10
247,Endothelin Pathways WP2197,0.5140500379047946,1.1896836107362423,0.7916567188396915,"['ADCY10', 'CALM1']",0.9228127186483662,0,0,2
248,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5140500379047946,1.1896836107362423,0.7916567188396915,"['FZD1', 'FGF1']",0.9228127186483662,0,0,2
249,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5140500379047946,1.1896836107362423,0.7916567188396915,"['FZD1', 'CREB3L1']",0.9228127186483662,0,0,2
250,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5287306094341642,1.405948481897849,0.8959775365317169,['DKK1'],0.9268336565375348,0,0,1
251,Cancer immunotherapy by CTLA4 blockade WP4582,0.5287306094341642,1.405948481897849,0.8959775365317169,['CD80'],0.9268336565375348,0,0,1
252,Iron metabolism in placenta WP2007,0.5287306094341642,1.405948481897849,0.8959775365317169,['HEPHL1'],0.9268336565375348,0,0,1
253,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5287306094341642,1.405948481897849,0.8959775365317169,['NFKBIA'],0.9268336565375348,0,0,1
254,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5287306094341642,1.405948481897849,0.8959775365317169,['LPL'],0.9268336565375348,0,0,1
255,Serotonin and anxiety-related events WP3944,0.5287306094341642,1.405948481897849,0.8959775365317169,['CRH'],0.9268336565375348,0,0,1
256,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5330935940638722,1.1455490578297596,0.7206171103663213,"['CDKN1B', 'FOXO4']",0.9273127454422639,0,0,2
257,TYROBP causal network in microglia WP3945,0.5354240010050964,1.0789109472490073,0.6739916991366616,"['IGSF6', 'NCF2', 'IL18']",0.9273127454422639,0,0,3
258,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5501667523660171,1.0543237250554325,0.6299941257410643,"['NFKBIA', 'ELK1', 'MAPK3']",0.9273127454422639,0,0,3
259,Melanoma WP4685,0.5502601097500774,1.030859375,0.6157984711510114,"['CALM3', 'CALM1', 'ELK1', 'MAPK3']",0.9273127454422639,0,0,4
260,Glioblastoma signaling pathways WP2261,0.5510164211452903,1.0172608941709111,0.6062779996760581,"['CDKN1B', 'PRKCH', 'CDKN2C', 'FOXO4', 'MAPK3']",0.9273127454422639,0,0,5
261,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5573801501905538,1.2887049659201557,0.7532580735442909,['TNC'],0.9273127454422639,0,0,1
262,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5573801501905538,1.2887049659201557,0.7532580735442909,['CCK'],0.9273127454422639,0,0,1
263,Ganglio Sphingolipid Metabolism WP1423,0.5573801501905538,1.2887049659201557,0.7532580735442909,['FUT1'],0.9273127454422639,0,0,1
264,Homologous recombination WP186,0.5573801501905538,1.2887049659201557,0.7532580735442909,['RAD51'],0.9273127454422639,0,0,1
265,IL-9 signaling pathway WP22,0.5573801501905538,1.2887049659201557,0.7532580735442909,['MAPK3'],0.9273127454422639,0,0,1
266,Nephrogenesis WP5052,0.5573801501905538,1.2887049659201557,0.7532580735442909,['PAX2'],0.9273127454422639,0,0,1
267,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5573801501905538,1.2887049659201557,0.7532580735442909,['PTTG1'],0.9273127454422639,0,0,1
268,Cytosolic DNA-sensing pathway WP4655,0.5646294517158268,1.030829268292683,0.5892071664974566,"['NFKBIA', 'CASP8', 'IL18']",0.9273127454422639,0,0,3
269,IL-4 signaling pathway WP395,0.5646294517158268,1.030829268292683,0.5892071664974566,"['NFKBIA', 'ELK1', 'MAPK3']",0.9273127454422639,0,0,3
270,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5646294517158268,1.030829268292683,0.5892071664974566,"['HOMER1', 'BDNF', 'MAPK3']",0.9273127454422639,0,0,3
271,Fluoropyrimidine Activity WP1601,0.5696198998684973,1.066411238825032,0.60016129724735,"['CYP2A6', 'TYMP']",0.9273127454422639,0,0,2
272,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5696198998684973,1.066411238825032,0.60016129724735,"['NFKBIA', 'JUN']",0.9273127454422639,0,0,2
273,Neovascularisation processes WP4331,0.5696198998684973,1.066411238825032,0.60016129724735,"['RELB', 'MAPK3']",0.9273127454422639,0,0,2
274,Wnt signaling in kidney disease WP4150,0.5696198998684973,1.066411238825032,0.60016129724735,"['FZD1', 'WNT6']",0.9273127454422639,0,0,2
275,Androgen receptor signaling pathway WP138,0.5837945209895351,0.9784451291188735,0.5266052404164517,"['JUN', 'RNF6', 'FKBP4', 'ETV5', 'RHOB']",0.9273127454422639,0,0,5
276,Airway smooth muscle cell contraction WP4962,0.5842896055214752,1.1894989139390308,0.6391873749915103,['CALM1'],0.9273127454422639,0,0,1
277,Cysteine and methionine catabolism WP4504,0.5842896055214752,1.1894989139390308,0.6391873749915103,['SQOR'],0.9273127454422639,0,0,1
278,Fatty acid transporters WP5061,0.5842896055214752,1.1894989139390308,0.6391873749915103,['ACSBG2'],0.9273127454422639,0,0,1
279,Galanin receptor pathway WP4970,0.5842896055214752,1.1894989139390308,0.6391873749915103,['CDKN1B'],0.9273127454422639,0,0,1
280,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5842896055214752,1.1894989139390308,0.6391873749915103,['ALPL'],0.9273127454422639,0,0,1
281,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5842896055214752,1.1894989139390308,0.6391873749915103,['FN1'],0.9273127454422639,0,0,1
282,Fatty acid beta-oxidation WP143,0.587090619597675,1.0307992202729044,0.5489790219778498,"['TPI1', 'LPL']",0.9273127454422639,0,0,2
283,Neural Crest Cell Migration during Development WP4564,0.587090619597675,1.0307992202729044,0.5489790219778498,"['JUN', 'BDNF']",0.9273127454422639,0,0,2
284,BDNF-TrkB Signaling WP3676,0.6040293991133593,0.9974847513047853,0.5028643898211753,"['HOMER1', 'BDNF']",0.9359508589205466,0,0,2
285,Melatonin metabolism and effects WP3298,0.6040293991133593,0.9974847513047853,0.5028643898211753,"['PER2', 'CALM1']",0.9359508589205466,0,0,2
286,Phosphodiesterases in neuronal function WP4222,0.6062646787560382,0.9662195121951219,0.4835335637856404,"['ADCY10', 'PDE10A', 'PDE6A']",0.9359508589205466,0,0,3
287,Translation Factors WP107,0.6062646787560382,0.9662195121951219,0.4835335637856404,"['EIF4A2', 'EIF1AX', 'EEF1A2']",0.9359508589205466,0,0,3
288,Biomarkers for pyrimidine metabolism disorders WP4584,0.6095645660957234,1.1044651550980664,0.5467217412843339,['TYMP'],0.9359508589205466,0,0,1
289,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.6095645660957234,1.1044651550980664,0.5467217412843339,['FRAT1'],0.9359508589205466,0,0,1
290,Mitochondrial complex III assembly WP4921,0.6095645660957234,1.1044651550980664,0.5467217412843339,['UQCC3'],0.9359508589205466,0,0,1
291,Overview of nanoparticle effects WP3287,0.6095645660957234,1.1044651550980664,0.5467217412843339,['FN1'],0.9359508589205466,0,0,1
292,ErbB signaling pathway WP673,0.6152363320014523,0.9424695419974728,0.45780345407103434,"['SHC4', 'JUN', 'CDKN1B', 'ELK1', 'MAPK3']",0.9359508589205466,0,0,5
293,Cardiac Hypertrophic Response WP2795,0.6195404292268328,0.9464410154305625,0.45313449194252914,"['NFATC2', 'CALM1', 'MAPK3']",0.9359508589205466,0,0,3
294,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6195404292268328,0.9464410154305625,0.45313449194252914,"['MSTN', 'HES1', 'ACTB']",0.9359508589205466,0,0,3
295,p38 MAPK Signaling Pathway WP400,0.6204363336382231,0.9662524366471735,0.4612234830233608,"['HSPB1', 'ELK1']",0.9359508589205466,0,0,2
296,Parkinson's disease pathway WP2371,0.6204363336382231,0.9662524366471735,0.4612234830233608,"['PINK1', 'CYCS']",0.9359508589205466,0,0,2
297,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6218733894841216,0.9367897727272727,0.4449927170149676,"['JUN', 'CYCS', 'NTN1', 'MAPK3']",0.9359508589205466,0,0,4
298,IL-1 signaling pathway WP195,0.6325083266468411,0.9274536585365853,0.4248311792484986,"['NFKBIA', 'JUN', 'MAPK3']",0.9362746975006533,0,0,3
299,PPAR signaling pathway WP3942,0.6325083266468411,0.9274536585365853,0.4248311792484986,"['ACOX2', 'LPL', 'ACSBG2']",0.9362746975006533,0,0,3
300,Serotonin and anxiety WP3947,0.6333042210288465,1.0307692307692307,0.47085988943643325,['CRH'],0.9362746975006533,0,0,1
301,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6363134681821394,0.9369129895445685,0.4235445986317037,"['JUN', 'MAPK3']",0.9362746975006533,0,0,2
302,Neural Crest Cell Migration in Cancer WP4565,0.6363134681821394,0.9369129895445685,0.4235445986317037,"['JUN', 'BDNF']",0.9362746975006533,0,0,2
303,B Cell Receptor Signaling Pathway WP23,0.6452397646044797,0.9090334080846415,0.39827780979524635,"['NFKBIA', 'JUN', 'CD81', 'NFATC2', 'ELK1']",0.9362746975006533,0,0,5
304,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6516645607655777,0.9092993922715285,0.389385029412494,"['MSTN', 'IGFBP5']",0.9362746975006533,0,0,2
305,IL-2 signaling pathway WP49,0.6516645607655777,0.9092993922715285,0.389385029412494,"['JUN', 'MAPK3']",0.9362746975006533,0,0,2
306,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6516645607655777,0.9092993922715285,0.389385029412494,"['GABRQ', 'BDNF']",0.9362746975006533,0,0,2
307,Wnt signaling pathway and pluripotency WP399,0.6549078987626253,0.8984064197867648,0.38026009940683886,"['FZD1', 'WNT6', 'FRAT1', 'JUN', 'PRKCH']",0.9362746975006533,0,0,5
308,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.6556017456771912,0.9662852969814996,0.40796736212994356,['MAPK3'],0.9362746975006533,0,0,1
309,Complement Activation WP545,0.6556017456771912,0.9662852969814996,0.40796736212994356,['MASP2'],0.9362746975006533,0,0,1
310,GDNF/RET signaling axis WP4830,0.6556017456771912,0.9662852969814996,0.40796736212994356,['PAX2'],0.9362746975006533,0,0,1
311,"GPCRs, Class B Secretin-like WP334",0.6556017456771912,0.9662852969814996,0.40796736212994356,['ADGRG2'],0.9362746975006533,0,0,1
312,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.6556017456771912,0.9662852969814996,0.40796736212994356,['EIF1AX'],0.9362746975006533,0,0,1
313,Pyrimidine metabolism and related diseases WP4225,0.6556017456771912,0.9662852969814996,0.40796736212994356,['TYMP'],0.9362746975006533,0,0,1
314,G13 Signaling Pathway WP524,0.6664948670386057,0.8832637148426622,0.35836026352660416,"['IQGAP2', 'CALM1']",0.9480108642665405,0,0,2
315,Ebola Virus Pathway on Host WP4217,0.6735755647134964,0.8828068213586805,0.3488456110431454,"['ACTB', 'ACTG1', 'RHOB', 'HLA-DQB1', 'RELB', 'MAPK3']",0.9480108642665405,0,0,6
316,15q13.3 copy number variation syndrome WP4942,0.6765446659978219,0.909387708345266,0.3553494385336794,['GOLGA8H'],0.9480108642665405,0,0,1
317,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6765446659978219,0.909387708345266,0.3553494385336794,['MAPK3'],0.9480108642665405,0,0,1
318,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6765446659978219,0.909387708345266,0.3553494385336794,['CD80'],0.9480108642665405,0,0,1
319,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6765446659978219,0.909387708345266,0.3553494385336794,['FN1'],0.9480108642665405,0,0,1
320,Lung fibrosis WP3624,0.6808109448905426,0.8586744639376218,0.33013510811227764,"['IL5', 'FGF1']",0.9480451475578584,0,0,2
321,Vitamin B12 metabolism WP1533,0.6808109448905426,0.8586744639376218,0.33013510811227764,"['SAA2', 'PLG']",0.9480451475578584,0,0,2
322,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6962152005397655,0.8588120740019474,0.310972820613789,['CASP8'],0.955045758793481,0,0,1
323,miRNA targets in ECM and membrane receptors WP2911,0.6962152005397655,0.8588120740019474,0.310972820613789,['FN1'],0.955045758793481,0,0,1
324,Nucleotide metabolism WP404,0.6962152005397655,0.8588120740019474,0.310972820613789,['OAZ1'],0.955045758793481,0,0,1
325,RAS and bradykinin pathways in COVID-19 WP4969,0.6962152005397655,0.8588120740019474,0.310972820613789,['REN'],0.955045758793481,0,0,1
326,Nephrotic syndrome WP4758,0.7079321105200901,0.813378475428337,0.280946683304525,"['MYO1E', 'PAX2']",0.955045758793481,0,0,2
327,22q11.2 copy number variation syndrome WP4657,0.7092944707071486,0.8394959411789706,0.28835384883502496,"['SLC7A4', 'ACTC1', 'SERPIND1', 'HES1', 'FGF10']",0.955045758793481,0,0,5
328,p53 transcriptional gene network WP4963,0.7145593986937143,0.813196405648267,0.27330649025070247,"['DRAM1', 'NCF2', 'RPRM']",0.955045758793481,0,0,3
329,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7146905822726792,0.813560190642136,0.2732794093447374,['MAPK3'],0.955045758793481,0,0,1
330,Triacylglyceride synthesis WP325,0.7146905822726792,0.813560190642136,0.2732794093447374,['LPL'],0.955045758793481,0,0,1
331,Vitamin D in inflammatory diseases WP4482,0.7146905822726792,0.813560190642136,0.2732794093447374,['NFKBIA'],0.955045758793481,0,0,1
332,Amino Acid metabolism WP3925,0.7148270698262644,0.82390625,0.27659737851512606,"['AOC3', 'TPH1', 'TPO', 'ALDH1A1']",0.955045758793481,0,0,4
333,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7207553113376857,0.7924726345778977,0.25949958088748787,"['JUN', 'MAPK3']",0.955045758793481,0,0,2
334,IL-6 signaling pathway WP364,0.7207553113376857,0.7924726345778977,0.25949958088748787,"['PRDM1', 'MAPK3']",0.955045758793481,0,0,2
335,G1 to S cell cycle control WP45,0.7250416951715153,0.799125315391085,0.2569396582154561,"['CDKN1B', 'CDKN2C', 'CREB3L1']",0.955045758793481,0,0,3
336,DNA damage response (only ATM dependent) WP710,0.7260214426225452,0.8215303342276575,0.2630340739040186,"['WNT6', 'FRAT1', 'JUN', 'CDKN1B', 'BIK']",0.955045758793481,0,0,5
337,Endoderm differentiation WP2853,0.7294566506131787,0.827264467430808,0.26096499070597484,"['DUSP4', 'DUSP5', 'DUSP2', 'DKK1', 'GRHL2', 'NODAL']",0.955045758793481,0,0,6
338,Differentiation of white and brown adipocyte WP2895,0.7320433603132069,0.7728334956183057,0.2410587704498863,['HSPB7'],0.955045758793481,0,0,1
339,Eicosanoid Synthesis WP167,0.7320433603132069,0.7728334956183057,0.2410587704498863,['PTGES'],0.955045758793481,0,0,1
340,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7320433603132069,0.7728334956183057,0.2410587704498863,['SCO2'],0.955045758793481,0,0,1
341,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7320433603132069,0.7728334956183057,0.2410587704498863,['BCL2L14'],0.955045758793481,0,0,1
342,Integrated Cancer Pathway WP1971,0.7331002334826173,0.7726120857699805,0.2398750702380089,"['CDKN1B', 'CASP8']",0.955045758793481,0,0,2
343,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7336445593092199,0.8313719581104498,0.25750135143559766,"['FZD1', 'WNT6', 'CLDN20', 'CLDN9', 'MMP15', 'FN1', 'MAPK3']",0.955045758793481,0,0,7
344,Endometrial cancer WP4155,0.7352204909368928,0.7855312112443158,0.24161748963762136,"['FGF1', 'ELK1', 'MAPK3']",0.955045758793481,0,0,3
345,Neural Crest Differentiation WP2064,0.7417926193214894,0.7920673076923077,0.2365790702579677,"['MIA', 'HES1', 'TBX6', 'RHOB']",0.955045758793481,0,0,4
346,IL-3 signaling pathway WP286,0.7449776001750996,0.7537203442209861,0.22189611948520188,"['JUN', 'MAPK3']",0.955045758793481,0,0,2
347,Interleukin-11 Signaling Pathway WP2332,0.7449776001750996,0.7537203442209861,0.22189611948520188,"['BGLAP', 'MAPK3']",0.955045758793481,0,0,2
348,TGF-beta Receptor Signaling WP560,0.7449776001750996,0.7537203442209861,0.22189611948520188,"['JUN', 'MAPK3']",0.955045758793481,0,0,2
349,NAD+ biosynthetic pathways WP3645,0.7483416840910477,0.7359855334538878,0.21335897399012346,['ACMSD'],0.955045758793481,0,0,1
350,Statin inhibition of cholesterol production WP430,0.7483416840910477,0.7359855334538878,0.21335897399012346,['LPL'],0.955045758793481,0,0,1
351,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7563985977710116,0.7357282094124199,0.2054056015266092,"['ADCY10', 'MAPK3']",0.955045758793481,0,0,2
352,EPO Receptor Signaling WP581,0.7636495694327898,0.7024873860316898,0.18942310603058224,['MAPK3'],0.955045758793481,0,0,1
353,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7636495694327898,0.7024873860316898,0.18942310603058224,['CASP8'],0.955045758793481,0,0,1
354,TLR4 Signaling and Tolerance WP3851,0.7636495694327898,0.7024873860316898,0.18942310603058224,['NFKBIA'],0.955045758793481,0,0,1
355,Male infertility WP4673,0.7647694272892521,0.7797920554518795,0.20912532964709898,"['ABCB1', 'MSH5', 'DND1', 'CLU', 'ETV5']",0.955045758793481,0,0,5
356,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7729733259052385,0.7354703832752614,0.1893915213419166,"['DUSP2', 'F2R', 'MAPK3']",0.955045758793481,0,0,3
357,Pathways Regulating Hippo Signaling WP4540,0.7746719757517738,0.7532393292682927,0.19231374852519886,"['NTRK1', 'PRKCH', 'PRKD3', 'FGFR4']",0.955045758793481,0,0,4
358,One-carbon metabolism and related pathways WP3940,0.7779179815942677,0.7021974127237285,0.17634577318140582,"['GPX4', 'GPX3']",0.955045758793481,0,0,2
359,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7779179815942677,0.7021974127237285,0.17634577318140582,"['EIF4A2', 'MAPK3']",0.955045758793481,0,0,2
360,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.778027149619678,0.6719021209940307,0.1686433060366456,['HIST1H3E'],0.955045758793481,0,0,1
361,Signal Transduction of S1P Receptor WP26,0.778027149619678,0.6719021209940307,0.1686433060366456,['MAPK3'],0.955045758793481,0,0,1
362,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.778027149619678,0.6719021209940307,0.1686433060366456,['TLR9'],0.955045758793481,0,0,1
363,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.778027149619678,0.6719021209940307,0.1686433060366456,['DKK1'],0.955045758793481,0,0,1
364,Chemokine signaling pathway WP3929,0.7782436078200947,0.7782565080826851,0.19512111214777494,"['SHC4', 'NFKBIA', 'GNG3', 'DOCK2', 'CXCL5', 'MAPK3']",0.955045758793481,0,0,6
365,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7816921568245487,0.7239329268292682,0.17830053702091916,"['ACTB', 'ACTG1', 'CACNG5']",0.955045758793481,0,0,3
366,G Protein Signaling Pathways WP35,0.7823556108046332,0.744117093373494,0.18264048710461064,"['GNG3', 'PRKCH', 'PRKD3', 'CALM1']",0.955045758793481,0,0,4
367,TGF-beta Signaling Pathway WP366,0.7846395410032148,0.7717221135029354,0.18716642022275556,"['KLF10', 'JUN', 'PARD6A', 'TNC', 'FN1', 'NEDD9']",0.955045758793481,0,0,6
368,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7880402427899108,0.6865497076023391,0.1635403426515533,"['JUN', 'MAPK3']",0.955045758793481,0,0,2
369,Cannabinoid receptor signaling WP3869,0.7915309101195867,0.6438656280428432,0.1505269936801165,['MAPK3'],0.955045758793481,0,0,1
370,MTHFR deficiency WP4288,0.7915309101195867,0.6438656280428432,0.1505269936801165,['CYCS'],0.955045758793481,0,0,1
371,Adipogenesis WP236,0.7926666141216587,0.7493190596854863,0.17410619929329305,"['FZD1', 'SFRP4', 'LPL', 'MIF', 'PRLR']",0.955045758793481,0,0,5
372,Synaptic Vesicle Pathway WP2267,0.7977537397068148,0.6715823374862276,0.15174760601380183,"['RAB3A', 'SLC18A2']",0.9585911872283501,0,0,2
373,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8042139099270679,0.6180720545277507,0.13467171258551858,['MAPK3'],0.9600218876674173,0,0,1
374,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8042139099270679,0.6180720545277507,0.13467171258551858,['PRLR'],0.9600218876674173,0,0,1
375,Non-small cell lung cancer WP4255,0.8061998872422558,0.6913869676010193,0.148941047541539,"['CASP8', 'CYCS', 'MAPK3']",0.9600218876674173,0,0,3
376,Wnt Signaling Pathway WP363,0.8160034682387808,0.6435185185185185,0.13085091504206953,"['FRAT1', 'NFATC2']",0.9600218876674173,0,0,2
377,Ethanol effects on histone modifications WP3996,0.8161259895159252,0.5942626020522808,0.12074616019134336,['ALDH1A1'],0.9600218876674173,0,0,1
378,IL17 signaling pathway WP2112,0.8161259895159252,0.5942626020522808,0.12074616019134336,['MAPK3'],0.9600218876674173,0,0,1
379,Nanoparticle-mediated activation of receptor signaling WP2643,0.8161259895159252,0.5942626020522808,0.12074616019134336,['FN1'],0.9600218876674173,0,0,1
380,Oxidative Stress WP408,0.8161259895159252,0.5942626020522808,0.12074616019134336,['GPX3'],0.9600218876674173,0,0,1
381,Cell cycle WP179,0.8238174128539137,0.7144020853698273,0.13845566771970605,"['CDKN1B', 'CDKN2C', 'PTTG1', 'YWHAG', 'YWHAH']",0.9623504072179422,0,0,5
382,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8245642191598923,0.6303457055336754,0.12159384506918969,"['NFKBIA', 'CASP8']",0.9623504072179422,0,0,2
383,Oxidative phosphorylation WP623,0.8245642191598923,0.6303457055336754,0.12159384506918969,"['ATP6AP1', 'ATP6AP2']",0.9623504072179422,0,0,2
384,Genotoxicity pathway WP4286,0.8327651546432501,0.6176998050682261,0.11304129037132243,"['PLK3', 'PCDH8']",0.9665230034351102,0,0,2
385,Joubert Syndrome WP4656,0.8352326204112515,0.6522706973548609,0.11743808136492441,"['CETN2', 'ARL2', 'PDE6A']",0.9665230034351102,0,0,3
386,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.837821812893568,0.5517457226317986,0.09763131452006635,['CASP8'],0.9665230034351102,0,0,1
387,Sphingolipid pathway WP1422,0.837821812893568,0.5517457226317986,0.09763131452006635,['SERINC1'],0.9665230034351102,0,0,1
388,Base Excision Repair WP4752,0.8476908405708662,0.5326864318570997,0.08802072484283732,['FEN1'],0.9665230034351102,0,0,1
389,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8476908405708662,0.5326864318570997,0.08802072484283732,['PLG'],0.9665230034351102,0,0,1
390,GABA receptor Signaling WP4159,0.8476908405708662,0.5326864318570997,0.08802072484283732,['GABRQ'],0.9665230034351102,0,0,1
391,Genes controlling nephrogenesis WP4823,0.8476908405708662,0.5326864318570997,0.08802072484283732,['PAX2'],0.9665230034351102,0,0,1
392,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8481357329127089,0.5938671464987254,0.09781858568899239,"['RAD51', 'H2AFX']",0.9665230034351102,0,0,2
393,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8544749756420457,0.625708635464733,0.09840398462398771,"['FZD1', 'CALM1', 'MAPK3']",0.9665230034351102,0,0,3
394,The influence of laminopathies on Wnt signaling WP4844,0.856959849340545,0.5148977604673807,0.07948178691416855,['HES1'],0.9665230034351102,0,0,1
395,Zinc homeostasis WP3529,0.856959849340545,0.5148977604673807,0.07948178691416855,['SLC30A2'],0.9665230034351102,0,0,1
396,DNA IR-damage and cellular response via ATR WP4016,0.8604382766722972,0.6173268292682926,0.09279249184751456,"['FEN1', 'RAD51', 'H2AFX']",0.9665230034351102,0,0,3
397,MET in type 1 papillary renal cell carcinoma WP4205,0.8687897769762739,0.5613680666312245,0.07895871833036958,"['JUN', 'MAPK3']",0.9665230034351102,0,0,2
398,Notch Signaling Pathway Netpath WP61,0.8687897769762739,0.5613680666312245,0.07895871833036958,"['HEY1', 'HES1']",0.9665230034351102,0,0,2
399,Thermogenesis WP4321,0.8693328866281894,0.6361549613402062,0.0890802438813917,"['ADCY10', 'CREB3L1', 'ACTB', 'ACTG1']",0.9665230034351102,0,0,4
400,Focal Adhesion WP306,0.8734480536713716,0.7044929971988796,0.0953225665156405,"['SHC4', 'JUN', 'FN1', 'TNC', 'ELK1', 'ACTB', 'ACTG1', 'MAPK3']",0.9665230034351102,0,0,8
401,Alpha 6 Beta 4 signaling pathway WP244,0.8738413845526857,0.48265579357351507,0.06508922372657766,['MAPK3'],0.9665230034351102,0,0,1
402,Nuclear receptors WP170,0.8738413845526857,0.48265579357351507,0.06508922372657766,['NR4A1'],0.9665230034351102,0,0,1
403,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8738413845526857,0.48265579357351507,0.06508922372657766,['ANGPT2'],0.9665230034351102,0,0,1
404,Type 2 papillary renal cell carcinoma WP4241,0.8738413845526857,0.48265579357351507,0.06508922372657766,['ELOB'],0.9665230034351102,0,0,1
405,Proteasome Degradation WP183,0.8810904643337824,0.5416025443726274,0.06856416036130046,"['H2AFX', 'UBC']",0.9665230034351102,0,0,2
406,Microglia Pathogen Phagocytosis Pathway WP3937,0.8815203029030148,0.46800035407630347,0.05901823539967375,['NCF2'],0.9665230034351102,0,0,1
407,Target Of Rapamycin (TOR) Signaling WP1471,0.8815203029030148,0.46800035407630347,0.05901823539967375,['RRAGA'],0.9665230034351102,0,0,1
408,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8821954930682885,0.5859215807347947,0.07344034844238333,"['MC4R', 'TPO', 'PAX8']",0.9665230034351102,0,0,3
409,Bladder cancer WP2828,0.8887322461033386,0.45420699925539837,0.0535779280228902,['TYMP'],0.9713039462302993,0,0,1
410,Pancreatic adenocarcinoma pathway WP4263,0.9008785908042186,0.5575433441081399,0.05819903922498093,"['RAD51', 'DUSP6', 'MAPK3']",0.9768545079695498,0,0,3
411,Development of ureteric collection system WP5053,0.9018669725964676,0.428919182083739,0.044302311832197114,['PAX2'],0.9768545079695498,0,0,1
412,Hedgehog Signaling Pathway WP4249,0.9018669725964676,0.428919182083739,0.044302311832197114,['EVC'],0.9768545079695498,0,0,1
413,Pathways affected in adenoid cystic carcinoma WP3651,0.9025523753723134,0.505959799316141,0.05187532802546186,"['INSRR', 'FGFR4']",0.9768545079695498,0,0,2
414,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.911873204258212,0.4898357003620161,0.045189463853252315,"['RBP4', 'LPL']",0.9845587495251708,0,0,2
415,DNA Replication WP466,0.9187222246481761,0.3958504980900307,0.033556824897393756,['UBC'],0.9872927862915082,0,0,1
416,Splicing factor NOVA regulated synaptic proteins WP4148,0.9236713754899768,0.3859298928919182,0.0306424185561648,['NCDN'],0.9872927862915082,0,0,1
417,Notch Signaling WP268,0.9283194303539911,0.37649321965468924,0.02800333664970016,['HES1'],0.9872927862915082,0,0,1
418,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9326846903863054,0.36750591180970926,0.025610784205053583,['CP'],0.9872927862915082,0,0,1
419,DNA Repair Pathways Full Network WP4946,0.9359604097038556,0.5359714673913043,0.03547171764010423,"['FEN1', 'RAD51', 'CETN2', 'H2AFX']",0.9872927862915082,0,0,4
420,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9367843454794701,0.3589366182831005,0.02343934274787668,['DHCR24'],0.9872927862915082,0,0,1
421,Nucleotide Excision Repair WP4753,0.9367843454794701,0.3589366182831005,0.02343934274787668,['CETN2'],0.9872927862915082,0,0,1
422,Mesodermal commitment pathway WP2857,0.9385469836681175,0.531317349137931,0.033697401092393275,"['TBX6', 'DKK1', 'GRHL2', 'NODAL']",0.9872927862915082,0,0,4
423,7q11.23 copy number variation syndrome WP4932,0.9392520412374749,0.4919564089257914,0.030831607348889702,"['H2AFX', 'GAPDH', 'MAPK3']",0.9872927862915082,0,0,3
424,Leptin signaling pathway WP2034,0.9414090300709078,0.43442330395629136,0.02622941818290865,"['ELK1', 'MAPK3']",0.9872927862915082,0,0,2
425,Integrated breast cancer pathway WP1984,0.9422567099194067,0.5539849645210517,0.032949654961090764,"['PLK3', 'JUN', 'CASP8', 'RAD51', 'RHO']",0.9872927862915082,0,0,5
426,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.9442504439515118,0.3429406037000974,0.01967239239844228,['HSPA5'],0.9872927862915082,0,0,1
427,Histone Modifications WP2369,0.9442504439515118,0.3429406037000974,0.01967239239844228,['HIST1H3E'],0.9872927862915082,0,0,1
428,Ciliary landscape WP4352,0.9453273211023837,0.6092797515045623,0.034256169073631416,"['EXOSC4', 'NEFL', 'COPS7A', 'NEFM', 'IQGAP2', 'CALM1', 'DYNLL1', 'DYNLL2']",0.9872927862915082,0,0,8
429,Mitochondrial complex I assembly model OXPHOS system WP4324,0.95664333520579,0.3148659658605409,0.013956322940410154,['NDUFB11'],0.9967822164032357,0,0,1
430,Interferon type I signaling pathways WP585,0.9592848972663908,0.3085491723466407,0.012825516139717767,['ZAP70'],0.997210114135062,0,0,1
431,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9633529803237684,0.3853313840155945,0.014386498253621316,"['SHC4', 'MAPK3']",0.9991155039552772,0,0,2
432,Nonalcoholic fatty liver disease WP4396,0.9674636848830078,0.4700322041984733,0.015547438430856299,"['JUN', 'CASP8', 'NDUFB11', 'CYCS']",0.9993387277108298,0,0,4
433,Kit receptor signaling pathway WP304,0.9702675601468908,0.28041072851199433,0.008463752076040386,['MAPK3'],0.9993387277108298,0,0,1
434,MECP2 and Associated Rett Syndrome WP3584,0.9841485895164425,0.23712081492023068,0.003788808318212492,['BDNF'],0.9993387277108298,0,0,1
435,Insulin Signaling WP481,0.9866660237234129,0.40725889900662254,0.005466909864696545,"['JUN', 'PRKCH', 'ELK1', 'MAPK3']",0.9993387277108298,0,0,4
436,Genes related to primary cilium development (based on CRISPR) WP4536,0.9874605811836585,0.30787524366471736,0.003884985581160436,"['EVC', 'DYNLL1']",0.9993387277108298,0,0,2
437,Hippo-Merlin Signaling Dysregulation WP4541,0.9881258420196033,0.30480767374983114,0.003640994379249233,"['NTRK1', 'FGFR4']",0.9993387277108298,0,0,2
438,Head and Neck Squamous Cell Carcinoma WP4674,0.9884273230753704,0.22011406315203783,0.0025621632450465526,['CASP8'],0.9993387277108298,0,0,1
439,Ciliopathies WP4803,0.9939529617385382,0.3656529017857143,0.0022178295162162544,"['DNAH11', 'RSPH4A', 'EVC', 'CCDC65']",0.9993387277108298,0,0,4
440,Pyrimidine metabolism WP4022,0.9942092669733829,0.19008979768473439,0.0011039587284580323,['TYMP'],0.9993387277108298,0,0,1
441,Retinoblastoma gene in cancer WP2446,0.9942092669733829,0.19008979768473439,0.0011039587284580323,['CDKN1B'],0.9993387277108298,0,0,1
442,Fragile X Syndrome  WP4549,0.9945045968494627,0.2674633443512162,0.0014738723860838977,"['HOMER1', 'BDNF']",0.9993387277108298,0,0,2
443,Cytoplasmic Ribosomal Proteins WP477,0.9957731674189525,0.17898145422431558,0.0007581280133376164,['RPL15'],0.9993387277108298,0,0,1
444,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9958388178976749,0.25623781676413254,0.0010684768253571128,"['LPL', 'MAPK3']",0.9993387277108298,0,0,2
445,EGF/EGFR signaling pathway WP437,0.9964204256191772,0.3031193838254172,0.0010869850152710142,"['JUN', 'FOXO4', 'ELK1']",0.9993387277108298,0,0,3
446,Integrin-mediated Cell Adhesion WP185,0.9971030706018571,0.16724524787265568,0.0004852008113267493,['RHO'],0.9993387277108298,0,0,1
447,Ectoderm Differentiation WP2858,0.9996582737401778,0.12185283071359021,4.16474285038477e-05,['LY6E'],0.9996582737401778,0,0,1
